RxDoctor Payments Data

James Coghill, MD

Hematology & Oncology · Chapel Hill, NCNPI 1801000880

Payments from drug & device makers

$192,363in general payments, 2019–2025

Across 14 payments — averaging $13,740 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$123K
  • Sanofi US Services Inc.$69K

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$192,363 in reported general payments places this provider in the 75th percentile of 358 hematology & oncology providers in North Carolina.

See all hematology & oncology providers in North Carolina

Medicare billing

Part B allowed, 2024
$34,131
Medicare patients
56
Services billed
376

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JakafiRuxolitinib Phosphate51$842,389
ValacyclovirValacyclovir Hcl37$2,791
Budesonide DrBudesonide11$561
Prednisone31$188
Pantoprazole Sodium16$96
Amlodipine Besylate13$77
Gabapentin11$48

Paid to pharmacies, not to this prescriber.

Other hematology & oncology in Chapel Hill

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →